Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PSCA antibody

PSCA Reactivity: Human, Mouse WB, ELISA, IHC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7254328
  • Target See all PSCA Antibodies
    PSCA (Prostate Stem Cell Antigen (PSCA))
    Reactivity
    • 53
    • 20
    • 10
    • 2
    • 2
    • 2
    Human, Mouse
    Host
    • 44
    • 9
    • 1
    Rabbit
    Clonality
    • 46
    • 8
    Polyclonal
    Conjugate
    • 33
    • 6
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This PSCA antibody is un-conjugated
    Application
    • 47
    • 19
    • 13
    • 13
    • 11
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Characteristics
    Polyclonal Antibody
    Purification
    Antigen affinity purification
    Immunogen
    Synthetic peptide of human PSCA
    Isotype
    IgG
    Top Product
    Discover our top product PSCA Primary Antibody
  • Application Notes
    WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.78 mg/mL
    Buffer
    PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    PSCA (Prostate Stem Cell Antigen (PSCA))
    Alternative Name
    PSCA (PSCA Products)
    Synonyms
    PRO232 antibody, 2210408B04Rik antibody, PSCA antibody, prostate stem cell antigen antibody, PSCA antibody, Psca antibody, LOC482068 antibody
    Background
    PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40 % of primary prostate cancers and in as many as 100 % of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
    Molecular Weight

    Observed_MW: Refer to figures

    Calculated_MW: 13 kDa

    UniProt
    O43653
You are here:
Support